Considering that these analyses were not able to provide tools for disease severity prediction that could be helpful in clinical practice or a clinical trial setting, our group recently developed an algorithm identifying complement‐related variants in C3, CFH and THBD that predict COVID‐19 severity.17 Here, C3 is linked to COVID-19.